A chimaeric llβ-hydroxylase/aldosterone synthase gene causes glucocorticoid-remediable aldosteronism and human hypertension
The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Abstract
Glucocorticoid-remediable aldosteronism (GRA), an autosomal dominant disorder, is characterized by hypertension with variable hyperaldosteronism and by high levels of the abnormal adrenal steroids 18-oxocortisol and 18-hydroxycortisol, which are all under control of adrenocorticotropic hormone and suppressible by glucocorticoids. These abnormalities could result from ectopic expression of aldosterone synthase, which is normally expressed only in adrenal glomerulosa, in the adrenal fasciculata. Genes encoding aldosterone synthase and steroid 11 beta-hydroxylase (expressed in both adrenal fasciculata and glomerulosa), which are 95% identical and lie on chromosome 8q (refs 7, 10), are therefore candidate genes for GRA. Here we demonstrate complete linkage of GRA in a large kindred to a gene duplication arising from unequal crossing over, fusing the 5' regulatory region of 11 beta-hydroxylase to the coding sequences of aldosterone synthase (maximum lod score 5.23 for complete linkage, odds ratio of 170,000:1). This mutation can account for all the physiological abnormalities of GRA. Our result represents the demonstration of a mutation causing hypertension in otherwise phenotypically normal animals or humans.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Consistent with a tandem duplication event, the two human genes are closely linked, separated by 40 kb, exhibiting similar intron/exon structure, and 90 and 95% identity in the coding and non-coding sequences, respectively (59, 70).”
From Adrenal Mitochondria and Steroidogenesis: From Individual Proteins to Functional Protein Assemblies (2016) · cites this paper as [70]
In the citing paper
“Although gene conversion events in the CYP11B locus are rare, an unusual gene duplication, caused by unequal crossing over between the CYP11B1 and CYP11B2 genes, results in glucocorticoid-remediable aldosteronism (GRA) (490 -492).”
From The Molecular Biology, Biochemistry, and Physiology of Human Steroidogenesis and Its Disorders (2011) · cites this paper as [490]
In the citing paper
“The crossover results in one allele having a third, hybrid CYP11B gene in which the ACTHregulated promoter and the first few exons of CYP11B1 are fused in frame to most of the exons of CYP11B2, resulting in the zona fasciculata expression of a chimeric protein with aldosterone synthase activity (490, 491) (Fig. 12).”
From The Molecular Biology, Biochemistry, and Physiology of Human Steroidogenesis and Its Disorders (2011) · cites this paper as [490]
In the citing paper
“They are particularly important in patients in glucocorticoid remediable aldosteronism or with aldosterone-producing adenomas associated with KCNJ5 mutations [261,[264], [265], [266], [267], [268], [269], [270], [271], [272]].”
From Human steroid biosynthesis, metabolism and excretion are differentially reflected by serum and urine steroid metabolomes: a comprehensive review (2019) · cites this paper as [264]
In the citing paper
“Urinary excretion of aldosterone metabolites is increased (Fig. 6) (115, 124), with the urinary (18OHF+18oxoF)/THAldo ratio further supporting diagnosis (116); the urinary metabolite 18oxoTHF (Fig. 7) is characteristically increased.”
From Steroid Metabolome Analysis in Disorders of Adrenal Steroid Biosynthesis and Metabolism (2019) · cites this paper as [124]
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity
Feinberg, A. P., & Vogelstein, B. (1983) · Analytical Biochemistry · doi:10.1016/0003-2697(83)90418-9 · Cited by 24,887
Orita, M., Suzuki, Y., Sekiya, T., & Hayashi, K. (1989) · Genomics · doi:10.1016/0888-7543(89)90129-8 · Cited by 3,434
Hypertension : pathophysiology, diagnosis, and management
Laragh, J. H., & Brenner, B. M. (1995) · Raven Press eBooks · Cited by 1,932
Gilliland, G., Perrin, S., Blanchard, K., & Bunn, H. F. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.7.2725 · Cited by 1,454
Hypertension: Pathophysiology, Diagnosis, and Management
White, W. B. (1991) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1991.03460110128039 · Cited by 944
Polymorphic DNA region adjacent to the 5' end of the human insulin gene.
Bell, G. I., Karam, J. H., & Rutter, W. J. (1981) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.78.9.5759 · Cited by 889
Regulation of the synthesis of steroidogenic enzymes in adrenal cortical cells by ACTH
Simpson, E. R., & Waterman, M. R. (1988) · Annual Review of Physiology · doi:10.1146/annurev.ph.50.030188.002235 · Cited by 506
Sutherland, D. J., Ruse, J. L., & Laidlaw, J. C. (1966) · PubMed Central · Cited by 467
Characterization of two genes encoding human steroid 11 beta-hydroxylase (P-450(11) beta).
Mornet, É., Dupont, J., Vitek, A., & White, P. C. (1989) · PubMed · Cited by 440
Characterization of Two Genes Encoding Human Steroid 11β-Hydroxylase (P-45011β)
Mornet, E., Dupont, J., Vitek, A., & White, P. C. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)30030-4 · Cited by 405
Research works printed but not linked: 2
- Sutherland, D. J., Ruse, J. L. & Laidlaw, J. C. Can. med. Assoc. J. 95, 1109–1119 (1966).
- Pickering, G. W. in The Epidemiology of Hypertension (eds Stamler, J., Stamler, R. & Pullman, T. N.) 18–27 (Grune & Stratton, New York, 1967).
Cited by
Items 801–900 of 995
Characterization of polymorphisms at the 11β‐hydroxylase (CYP11B1) locus
Skinner, C., Yousaf, N., Honour, J. W., & Rumsby, G. (1998) · Annals of Human Genetics · doi:10.1046/j.1469-1809.1998.6220181.x · Cited by 6
Selection of Candidate Genes in Hypertension
Mein, C. A., Caulfield, M. J., & Munroe, P. B. (2005) · Humana Press eBooks · doi:10.1385/1-59259-850-1:107 · Cited by 5
Renal Hypokalemia: An Endocrine Perspective
Culver, S. A., Suleman, N., Kavuru, V., & Siragy, H. M. (2024) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgae201 · Cited by 9
Vaidya, A., Kline, G. A., Mulatero, P., Turcu, A. F., Williams, T. A., Wu, V., Yang, J., Zennaro, M., & Lacroix, A. (2026) · Nature Reviews Disease Primers · doi:10.1038/s41572-026-00714-w · Cited by 6
Sex-specific recombination patterns predict parent of origin for recurrent genomic disorders
Mosley, T. J., Johnston, H. R., Cutler, D. J., Zwick, M. E., & Mullé, J. G. (2021) · BMC Medical Genomics · doi:10.1186/s12920-021-00999-8 · Cited by 5
Karam, S., Cohen, D. L., Abou-Jaoudé, P., Dionne, J. M., Ding, F. L., Garg, A., Tannor, E. K., & Chanchlani, R. (2023) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2023.151438 · Cited by 6
Novel recurrent mutations and genetic diversity in Sudanese children with adrenal insufficiency
Musa, S. A., Abdullah, M. A., Hassan, S. S., Fauzi, L. S., Babiker, O., Ahmed, A. I., Mohammedali, M., Hutchison, C. E., Mohamadsalih, G., Hall, C. L., et al. (2025) · European Journal of Endocrinology · doi:10.1093/ejendo/lvaf037 · Cited by 4
Is Hypertension a Disorder of Volume Control? What Is the Evidence?
Mindel, G., & Morrison, A. R. (2005) · Nephron Physiology · doi:10.1159/000086871 · Cited by 4
Genetic Forms of Primary Aldosteronism
Stowasser, M., Fallo, F., So, A., Jeske, Y. W. A., Kelemen, L., Pilon, C., & Gordon, R. D. (2007) · High Blood Pressure & Cardiovascular Prevention · doi:10.2165/00151642-200714020-00004 · Cited by 4
[The role of molecular biology in the diagnosis and treatment of cardiovascular diseases].
Mariotti, S., Capparuccia, C., Ripa, C., Olivieri, F., Lisa, R., Procopio, A. D., & Antonicelli, R. (2010) · PubMed · Cited by 3
Familial Aggregation and Heritability of Aldosteronism with Cardiovascular Events
Wu, V., Chueh, S., Hsieh, M.-Y., Hu, Y., Huang, K., Lin, Y., Yang, S., Chu, T., & Kuo, C. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgz257 · Cited by 5
Steroid 11β-Hydroxylase Deficiency and Related Disorders
White, P. C. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-416006-4.00006-5 · Cited by 6
CaV3.2 (CACNA1H) in Primary Aldosteronism
Dinh, H. A., Stölting, G., & Scholl, U. I. (2023) · Handbook of experimental pharmacology · doi:10.1007/164_2023_660 · Cited by 7
Therapeutic management of congenital forms of endocrine hypertension
Charoensri, S., & Auchus, R. J. (2023) · European Journal of Endocrinology · doi:10.1093/ejendo/lvad140 · Cited by 4
Discovery of genes for essential hypertension
Morris, B. J. (1996) · Springer eBooks · doi:10.1007/978-94-009-0083-7_4 · Cited by 4
The molecular basis of a hereditary form of hypertension, glucocorticoid-remediable aldosteronism
Lifton, R. P., & Dluhy, R. G. (1993) · Trends in Endocrinology and Metabolism · doi:10.1016/s1043-2760(05)80016-5 · Cited by 5
Self-citationHiperaldosteronismo primario y secundario
Luque‐Ramírez, M., Buesa, M. A., Blasco, F. Á., & Escobar-Morreale, H. F. (2012) · Medicine - Programa de Formación Médica Continuada Acreditado · doi:10.1016/s0304-5412(12)70399-2 · Cited by 4
Niu, W.-Q., Guo, S.-J., Zhang, Y., Gao, P.-J., & Zhu, D.-L. (2010) · Journal of Human Hypertension · doi:10.1038/jhh.2010.12 · Cited by 4
Aldosterone as an Independent Factor in Cerebrovascular Damage
Mulatero, P., Caserta, M., Bertello, C., Schiavone, D., Verhovez, A., Giraudo, G., Morello, F., & Veglio, F. (2008) · Clinical and Experimental Hypertension · doi:10.1080/10641960802566017 · Cited by 4
Endocrine Causes of Hypertension—Aldosterone
Weiner, I. D., & Wingo, C. S. (2010) · Elsevier eBooks · doi:10.1016/b978-0-323-05876-6.00038-1 · Cited by 6
Precision Medicine in Adrenal Disorders: the Next Generation
Ghayee, H. K., Vinik, A. I., & Pacák, K. (2017) · Endocrine Practice · doi:10.4158/ep161716.ra · Cited by 4
Primary Mineralocorticoid Excess Disorders and Hypertension
Carey, R. M., & Padia, S. H. (2015) · Elsevier eBooks · doi:10.1016/b978-0-323-18907-1.00108-6 · Cited by 6
Etiology of Childhood Hypertension
Ingelfinger, J. R. (2008) · Elsevier eBooks · doi:10.1016/b978-0-323-04883-5.50049-0 · Cited by 5
Asp, A. A. (2009) · Elsevier eBooks · doi:10.1016/b978-0-323-05885-8.00027-1 · Cited by 4
Kaplan, N. M. (1995) · Endocrine Practice · doi:10.4158/ep.1.2.91 · Cited by 6
Steroid 11β-Hydroxylase Isozymes (CYP11B1 and CYP11B2)
White, P. C., Curnow, K. M., & Pascoe, L. (1993) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-77763-9_41 · Cited by 4
Mineralocorticoid Excess Syndromes
Gordon, R. D. (2001) · Humana Press eBooks · doi:10.1007/978-1-59259-101-5_27 · Cited by 5
Hiperaldosteronismo primario: subtipos y diagnóstico de localización
Pérez, A. J. P. (2001) · Hipertensión y Riesgo Vascular · doi:10.1016/s1889-1837(01)71158-0 · Cited by 4
Kolovou, G. D., & Mavrogeni, S. I. (2013) · Angiology · doi:10.1177/0003319713491135 · Cited by 5
Capricchione, A., Winer, N., & Sowers, J. R. (2004) · Current Hypertension Reports · doi:10.1007/s11906-004-0073-x · Cited by 4
Molecular and Genetics Perspectives on Primary Adrenocortical Hyperfunction Disorders
Kim, S., Chaudhary, P. K., & Kim, S. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252111341 · Cited by 7
Kelly, T. N., & He, J. (2012) · Progress in molecular biology and translational science · doi:10.1016/b978-0-12-398397-8.00010-1 · Cited by 3
Hypertension in young children and neonates
Jones, J. E., & José, P. A. (2005) · Current Hypertension Reports · doi:10.1007/s11906-005-0041-0 · Cited by 3
X-chromosome variants are associated with aldosterone producing adenomas
Dutta, R. K., Larsson, M., Arnesen, T., Heie, A., Walz, M. K., Alesina, P. F., Gimm, O., & Söderkvist, P. (2021) · Scientific Reports · doi:10.1038/s41598-021-89986-8 · Cited by 3
CRISPR/Cas9-induced gene conversion between ATAD3 paralogs
Yanovsky‐Dagan, S., Frumkin, A., Lupski, J. R., & Harel, T. (2022) · Human Genetics and Genomics Advances · doi:10.1016/j.xhgg.2022.100092 · Cited by 4
Costa‐Barbosa, F. A., Giorgi, R. B., & Kater, C. E. (2022) · Archives of Endocrinology and Metabolism · doi:10.20945/2359-3997000000507 · Cited by 3
Steroid 11β-hydroxylase deficiency and related disorders
White, P. C. (2023) · Elsevier eBooks · doi:10.1016/b978-0-12-821424-4.00010-1 · Cited by 5
Neglected issues concerning teaching human adrenal steroidogenesis in popular biochemistry textbooks
Han, Z., & Elliott, M. S. (2017) · Biochemistry and Molecular Biology Education · doi:10.1002/bmb.21069 · Cited by 3
Timeline of Advances in Genetics of Primary Aldosteronism
Meyer, L. S., Reincke, M., & Williams, T. A. (2019) · Experientia supplementum · doi:10.1007/978-3-030-25905-1_11 · Cited by 3
Systematic approach to the diagnosis and management of endocrine hypertension
Stowasser, M., Jansen, P. M., & Wolley, M. J. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-96120-2.00009-1 · Cited by 4
Rat Genome Mapping and Genomics
Szpirer, C., & Levan, G. (2012) · Springer eBooks · doi:10.1007/978-3-642-31316-5_9 · Cited by 3
Comparative genetic analysis of different forms of low-renin arterial hypertension
Михайловна, Ч. Н., Самедова, Х. Ф., Sudomoina, M. A., Min, K., Koliadina, J. A., Литонова, Г. Н., Favorov, A. V., Chazova, I. E., & Favorova, O. O. (2008) · Molecular Biology · doi:10.1134/s0026893308040067 · Cited by 3
Inhibition of aldosterone biosynthesis by staurosporine
Bureik, M., Mion, A., Kenyon, C. J., & Bernhardt, R. (2005) · Biological Chemistry · doi:10.1515/bc.2005.077 · Cited by 3
Pathophysiology and diagnosis of primary aldosteronism
Suzuki, H. (2000) · Biomedicine & Pharmacotherapy · doi:10.1016/s0753-3322(00)80027-x · Cited by 3
Beta-2 adrenoreceptor gene polymorphisms and sympathetic outflow in humans
Tank, J., Heusser, K., Diedrich, A., Hering, D., Luft, F. C., Busjahn, A., Aydın, A., Limon, J., Narkiewicz, K., & Jordan, J. (2011) · Clinical Autonomic Research · doi:10.1007/s10286-011-0121-y · Cited by 3
Hyperaldosteronism: How to Discriminate Among Different Disease Forms?
Crudo, V. L., Monticone, S., Burrello, J., Buffolo, F., Tetti, M., Veglio, F., & Mulatero, P. (2016) · High Blood Pressure & Cardiovascular Prevention · doi:10.1007/s40292-016-0151-6 · Cited by 4
The Genetics of Blood Pressure Regulation
Lin, H. J., Guo, X., & Rotter, J. I. (2020) · Emery and Rimoin's Principles and Practice of Medical Genetics and Genomics · doi:10.1016/b978-0-12-812532-8.00006-9 · Cited by 3
Gennari, F. J. (2012) · Springer eBooks · doi:10.1007/978-1-4614-3770-3_9 · Cited by 3
Childhood Hypertension: Epidemiology, Etiology, Target Organ Damage, and Consequences
Lurbe, E., & Simonetti, G. D. (2016) · Springer eBooks · doi:10.1007/978-3-662-52972-0_49 · Cited by 3
Stankiewicz, P., & Lupski, J. R. (2020) · doi:10.1093/med/9780198746690.003.0030 · Cited by 3
Aldosterone, Normotension, and Diastolic Dysfunction
Funder, J. W. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-1613 · Cited by 3
Understanding how aldosterone increases sodium transport
Stokes, J. B. (2000) · American Journal of Kidney Diseases · doi:10.1053/ajkd.2000.17720 · Cited by 4
Screening for primary aldosteronism: progress and frustration
Krakoff, L. R. (2006) · Journal of Hypertension · doi:10.1097/01.hjh.0000217843.80336.0d · Cited by 3
O espectro das síndromes de hipertensão esteróide na infância e adolescência
Kater, C. E., & Costa‐Santos, M. (2001) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302001000100011 · Cited by 7
Transgenesis and Gene Targeting in the Mouse
Stec, D. E., Davisson, R. L., & Sigmund, C. D. (1998) · Trends in Cardiovascular Medicine · doi:10.1016/s1050-1738(98)00016-4 · Cited by 6
Dissecting Hypertension: The Role of the 'New Genetics'
Jamieson, A. (1994) · Journal of the Royal College of Physicians of London · doi:10.1016/s0035-8819(25)00693-2 · Cited by 3
Glucocorticoid-suppressible hyperaldosteronism
Lu, Z. L., Zheng, Z., & Guan, B. J. (1992) · The Lancet · doi:10.1016/0140-6736(92)90543-c · Cited by 3
Bell, J. I. (1993) · Current Opinion in Genetics & Development · doi:10.1016/0959-437x(93)90121-5 · Cited by 3
Zeman, J., & Kamilaris, C. D. C. (2025) · Prague Medical Report · doi:10.14712/23362936.2025.23 · Cited by 3
Long, K. C., & Azizan, E. A. B. A. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1736534 · Cited by 3
Genetic mechanisms of primary aldosteronism
Fayad, M., Cosentino, T., Faedda, N., Boulkroun, S., Zennaro, M., & Fernandes-Rosa, F. L. (2026) · Annales d Endocrinologie · doi:10.1016/j.ando.2026.102558 · Cited by 3
Miscellaneous endocrine causes of hypertension
Auchus, R. J. (2005) · Current Cardiology Reports · doi:10.1007/s11886-005-0059-6 · Cited by 2
A Mother/Daughter Case of Familial Hyperaldosteronism
Somekh, N. N., & Finkielstein, D. (2010) · Clinical Cardiology · doi:10.1002/clc.20654 · Cited by 2
Evaluation and Management of Hypertension in Children
Larkins, N., Lurbe, E., & Flynn, J. T. (2022) · Springer eBooks · doi:10.1007/978-3-030-52719-8_123 · Cited by 2
Monogenic hypertension-a type of “curable” hypertension
Lu, Y., Fan, P. T., Hakonarson, H. H., Hu, A., Liu, Y., & Zhou, X. (2023) · 中国科学通报:英文版 · doi:10.1016/j.scib.2023.03.033 · Cited by 2
Unmasking primary aldosteronism: Transforming disease management with advanced steroid profiling
Zhong, J., Paljor, T., Yu, S., & Qiu, L. (2025) · Clinica Chimica Acta · doi:10.1016/j.cca.2025.120186 · Cited by 2
Renal Aspects of Sodium Metabolism in the Fetus and Neonate
Quigley, R. P. (2019) · Elsevier eBooks · doi:10.1016/b978-0-323-53367-6.00004-2 · Cited by 3
Monogenic and Polygenic Contributions to Hypertension
Ingelfinger, J. R. (2013) · Humana Press eBooks · doi:10.1007/978-1-62703-490-6_6 · Cited by 4
Adrenal Tumors in MEN1 Syndrome and the Role of Menin in Adrenal Tumorigenesis
Patócs, A., Balogh, K., & Rácz, K. (2009) · Advances in experimental medicine and biology · doi:10.1007/978-1-4419-1664-8_10 · Cited by 2
Sodium Balance and Hypertension: Rare Genetic Disorders Expose Pathogenic Mechanisms
Burnier, M. (1998) · Nephron Experimental Nephrology · doi:10.1159/000020563 · Cited by 3
Sampson, A. K., DASHTI, M. H., Beattie, W., Graham, D., Kenyon, C. J., Al‐Dujaili, E. A. S., Guryev, V., McBride, M., & Dominiczak, A. F. (2014) · Journal of Hypertension · doi:10.1097/hjh.0000000000000300 · Cited by 2
Bérard, E. (2008) · Néphrologie & Thérapeutique · doi:10.1016/j.nephro.2008.02.005 · Cited by 2
Fagard, R. H., & Kuznetsova, T. (2002) · Journal of Hypertension · doi:10.1097/00004872-200204000-00007 · Cited by 2
Ferri, C., Falaschi, P., Gualdi, G. F., Coassin, S., Carlomagno, A., Siati, L. D., Bonavita, M. S., & BALSANO, F. (1994) · Endocrine Research · doi:10.3109/07435809409030407 · Cited by 2
Monogenic Forms of Human Hypertension
Burke, B., Gungadoo, J., Marçano, A. C. B., Newhouse, S., Shiel, J. I., Caulfield, M. J., & Munroe, P. B. (2007) · Elsevier eBooks · doi:10.1016/b978-0-323-03961-1.50039-8 · Cited by 2
The Principles, Enzymes, and Pathways of Human Steroidogenesis
Auchus, R. J., & Miller, W. L. (2015) · Elsevier eBooks · doi:10.1016/b978-0-323-18907-1.00097-4 · Cited by 3
Glucocorticoid-Remediable Aldosteronism
Halperin, F., & Dluhy, R. G. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-416006-4.00019-3 · Cited by 3
Self-citationWhite, P. C. (2013) · Humana Press eBooks · doi:10.1007/978-1-62703-490-6_25 · Cited by 2
Glucocorticoid Remediable Aldosteronism
Comiter, C. V., Capelouto, C. C., Tobin, M. S., Dluhy, R. G., & Richie, J. P. (1995) · The Journal of Urology · doi:10.1097/00005392-199508000-00047 · Cited by 2
Self-citationVidal‐Petiot, E., Ayari, H., & Flamant, M. (2017) · EMC - Tratado de Medicina · doi:10.1016/s1636-5410(17)84233-1 · Cited by 2
Primary aldosteronism (Conn's syndrome)
Ceccato, F., Tizianel, I., Voltan, G., & Mantero, F. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-96120-2.00014-5 · Cited by 2
Familial Hyperaldosteronism Type II
Stowasser, M., & Gordon, R. D. (2014) · Springer eBooks · doi:10.1007/978-1-4939-0509-6_7 · Cited by 2
Olcay, A., Nişancí, Y., Ekmekçi, C. G., Özbek, U., Sezer, M., Umman, B., & Buğra, Z. (2007) · PubMed · Cited by 2
Genetics of Hypertension and Heart Failure
Padmanabhan, S., Aman, A., & Dominiczak, A. F. (2019) · Updates in hypertension and cardiovascular protection · doi:10.1007/978-3-319-93320-7_2 · Cited by 2
Sinha, M. D., & Reid, C. J. D. (2009) · Elsevier eBooks · doi:10.1016/b978-0-7020-3064-2.00062-x · Cited by 2
Конради, А. О. (2020) · Arterial’naya Gipertenziya (Arterial Hypertension) · doi:10.18705/1607-419x-2020-26-5-490-500 · Cited by 4
Adrenocortical Tumors and Oncogenes
Reincke, M. (2001) · Humana Press eBooks · doi:10.1007/978-1-59259-101-5_16 · Cited by 2
Lombès, M., Kenouch, S., Souque, A., Farman, N., Rafestin-Oblin, M. E., & Funder, J. W. (1995) · Journal of Endocrinological Investigation · doi:10.1007/bf03349770 · Cited by 2
Funder, J. W. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.6.6679 · Cited by 2
Use of animal models to search for candidate genes associated with essential hypertension
Knoblauch, M., & Lindpaintner, K. (1999) · Current Hypertension Reports · doi:10.1007/s11906-999-0070-1 · Cited by 2
Matteo, R. M. D., May, C. N., Coghlan, J. P., Kurosawa, T., Yoshimura, T., Chiba, H., & McDougall, J. G. (1997) · Steroids · doi:10.1016/s0039-128x(96)00245-0 · Cited by 2
THE APPLICATION OF MOLECULAR GENETIC TECHNIQUES TO THE STUDY OF HYPERTENSIVE DISEASES
Ré, R. N. (1997) · Medical Clinics of North America · doi:10.1016/s0025-7125(05)70569-1 · Cited by 2
Sporadic cases of Liddle's syndrome: Clues to essential hypertension?
Alper, S. L. (2001) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(01)80024-x · Cited by 2
The biochemical phenotypes of two inborn errors in the biosynthesis of aldosterone
Ulick, S., Wang, J. Z., Morton, D. H., & Pascoe, L. (1995) · Journal of Endocrinological Investigation · doi:10.1007/bf03349769 · Cited by 2
Self-citationNew Molecular Genetic Defects Causing 11β-Hydroxylase Deficiency (CAH)
Hampf, M., Dao, N. T. N., Hoàn, N. T., & Bernhardt, R. (2000) · Endocrine Research · doi:10.3109/07435800009048599 · Cited by 2
Hypertension: a disorder of volume control? what is the evidence?
Morrison, A. R., & Mindel, G. (2004) · Advances in Chronic Kidney Disease · doi:10.1053/j.arrt.2004.01.006 · Cited by 2
Hiperaldosteronismo primário: novas tendências
Kater, C. E. (2002) · Cited by 4
Disorders of Potassium Metabolism
Allon, M. (2009) · Elsevier eBooks · doi:10.1016/b978-1-4160-5185-5.00012-2 · Cited by 2
Secondary Hypertension: Adrenal and Nervous Systems
Bravo, E. L. (2001) · doi:10.1007/978-1-4684-6909-7_6 · Cited by 3
Metadata
- Authors
- Lifton, R. P., Dluhy, R. G., Powers, M., Rich, G. M., Cook, S., Ulick, S., & Lalouel, J.-M.
- Affiliations
- Howard Hughes Medical Institute (US)
- Brigham and Women's Hospital (US)
- Veterans Health Administration (US)
- ORCID
- Lifton, Richard P.
- Venue
- Nature
- Published
- 1992-01
- Volume
- 355
- Issue
- 6357
- Pages
- 262-265
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W1979069430
- Semantic Scholar
- 48f7453ea9e77a6f893ab90603be6343f5cad138
- Cited by
- 1,158
- References
- 23
- Citations by year
- 2026: 18 · 2025: 10 · 2024: 21 · 2023: 37 · 2022: 29 · 2021: 26 · 2020: 25 · 2019: 24 · 2018: 36 · 2017: 35 · 2016: 30 · 2015: 34 · 2014: 34 · 2013: 36 · 2012: 32
- FWCI
- 30.90
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal Regulation and Hypertension
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Renin-Angiotensin System Studies
- Keywords
- glucocorticoid-remediable aldosteronism, aldosterone synthase, 11β-hydroxylase, fusion genes, gene duplication, unequal crossover, hypertension, hyperaldosteronism, 18-oxocortisol, 18-hydroxycortisol, ACTH, chromosome 8q, genetic linkage, autosomal dominant disorder, adrenal glomerulosa
- MeSH terms
- Base Sequence, Chimera, Crossing Over, Genetic, Cytochrome P-450 Enzyme System, Exons, Female, Humans, Hyperaldosteronism, Hypertension, Introns, Male, Molecular Sequence Data, Oligodeoxyribonucleotides, Pedigree, Steroid Hydroxylases, Steroid 11-beta-Hydroxylase, Polymerase Chain Reaction, Cytochrome P-450 CYP11B2
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.